Unicycive (NASDAQ: UNCY) CEO receives 762,200 restricted stock units

Q: What equity award did Unicycive (UNCY) grant to its CEO?

Unicycive granted CEO Shalabh K. Gupta 762,200 restricted stock units (RSUs) payable in common stock. RSUs are stock-based compensation that convert into shares as they vest over time, aligning executive incentives with shareholder value.

Q: How many Unicycive RSUs vest immediately for CEO Shalabh Gupta?

Out of the 762,200 RSUs, 105,861 shares vest upon grant . Immediate vesting provides the CEO with a direct equity stake right away, while the remaining units follow a longer vesting schedule tied to continued service.

Q: What is the vesting schedule for the remaining Unicycive CEO RSUs?

Beyond the immediately vested portion, 21,172 shares vest over 31 months beginning June 1, 2026 . This time-based vesting encourages the CEO’s ongoing tenure and ties compensation to staying with Unicycive over multiple years.

Q: Does the Unicycive CEO Form 4/A show a stock market purchase or sale?

No, the Form 4/A reports a grant of restricted stock units , not an open-market trade. The RSUs were awarded at a stated price of $0.00 per unit as part of equity compensation, rather than being bought or sold on an exchange.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Gupta Shalabh K. reported acquisition or exercise transactions in this Form 4 filing.

Unicycive Therapeutics reported that CEO Shalabh K. Gupta received a grant of 762,200 restricted stock units (RSUs) payable in common stock. These RSUs are a form of equity compensation, not an open-market purchase or sale.

According to the award terms, 105,861 shares vest immediately upon grant. An additional 21,172 shares vest over 31 months beginning on June 1, 2026, contingent on Gupta’s continued service with the company. Following this grant, the Form 4/A shows Gupta holding 762,200 RSUs linked to common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gupta Shalabh K.

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	762,200	$0.00	--

Holdings After Transaction: Restricted Stock Units — 762,200 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 762,200 units Immediate vesting: 105,861 shares Time-based vesting portion: 21,172 shares +2 more

5 metrics

RSU grant size 762,200 units Restricted stock units granted to CEO Shalabh K. Gupta

Immediate vesting 105,861 shares Portion of RSUs that vest upon grant

Time-based vesting portion 21,172 shares Vest over 31 months beginning June 1, 2026

RSU price per unit $0.00 per unit Grant price for restricted stock units

RSUs after transaction 762,200 units Total RSUs held by CEO following the grant

Key Terms

Restricted Stock Units, RSU Award, vest upon grant, vest over 31 months, +1 more

5 terms

Restricted Stock Units financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU Award financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

vest upon grant financial

"105,861 shares vest upon grant and 21,172 shares vest over 31 months"

vest over 31 months financial

"21,172 shares vest over 31 months beginning June 1, 2026"

continued service financial

"subject to the Reporting Person's continued service with the Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/15/2026 - 05:25 PM Accepted by SEC EDGAR 06/15/2026 - 05:24 PM

FAQ

What equity award did Unicycive (UNCY) grant to its CEO?

Unicycive granted CEO Shalabh K. Gupta 762,200 restricted stock units (RSUs) payable in common stock. RSUs are stock-based compensation that convert into shares as they vest over time, aligning executive incentives with shareholder value.

How many Unicycive RSUs vest immediately for CEO Shalabh Gupta?

Out of the 762,200 RSUs, 105,861 shares vest upon grant. Immediate vesting provides the CEO with a direct equity stake right away, while the remaining units follow a longer vesting schedule tied to continued service.

What is the vesting schedule for the remaining Unicycive CEO RSUs?

Beyond the immediately vested portion, 21,172 shares vest over 31 months beginning June 1, 2026. This time-based vesting encourages the CEO’s ongoing tenure and ties compensation to staying with Unicycive over multiple years.

Does the Unicycive CEO Form 4/A show a stock market purchase or sale?

No, the Form 4/A reports a grant of restricted stock units, not an open-market trade. The RSUs were awarded at a stated price of $0.00 per unit as part of equity compensation, rather than being bought or sold on an exchange.

How many Unicycive RSUs does the CEO hold after this grant?

After this transaction, the filing shows CEO Shalabh K. Gupta holding 762,200 restricted stock units tied to Unicycive common stock. These units will convert into shares only as they vest according to the specified schedule and conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gupta Shalabh K.

(Last)

(First)

(Middle)

C/O UNICYCIVE THERAPEUTICS, INC.

1975 W. EL CAMINO REAL, SUITE 204

(Street)

MOUNTAIN VIEW

CALIFORNIA

94040

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/21/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	05/14/2026		A		762,200		⁽¹⁾	⁽¹⁾	Common Stock	762,200	$0	762,200	D

Explanation of Responses:

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 105,861 shares vest upon grant and 21,172 shares vest over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.

	/s/ Shalabh Gupta	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR